Literature DB >> 20112075

Regulation of the expression balance of angiopoietin-1 and angiopoietin-2 by Shh and FGF-2.

Takaaki Fujii1, Hiroyuki Kuwano.   

Abstract

Sonic hedgehog (Shh) is a typical morphogen to regulate epithelial-mesenchymal interactions during embryonic development. Shh is also an indirect angiogenic agent upregulating other angiogenic factors, including angiopoietin-1 (Ang-1). Recent studies revealed that angiogenesis induced by Shh is characterized by distinct large-diameter vessels with less branching. Ang-1 promotes blood vessel maturation, and angiopoietin-2 (Ang-2) counteracts Ang-1 activity and regulates vascular branching. Thus, we hypothesized that Shh-induced angiogenesis is affected by expression of Ang-1 and Ang-2, and we investigated the regulatory system of angiopoietins by Shh in vitro. Shh enhanced Ang-1 expression but did not enhance vascular endothelial growth factor in fibroblasts. The upregulation of Ang-1 expression by Shh was significantly decreased by fibroblast growth factor-2 (FGF-2), a potent angiogenic factor. Furthermore, FGF-2 increased the expression of Ang-2 in endothelial cells. These findings suggest that Shh and FGF-2 regulate the expression balance of vascular morphogens Ang-1 and Ang-2 and are involved in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20112075     DOI: 10.1007/s11626-009-9270-x

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  29 in total

1.  Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts.

Authors:  Sae-Won Lee; Michael A Moskowitz; John R Sims
Journal:  Int J Mol Med       Date:  2007-03       Impact factor: 4.101

2.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.

Authors:  T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

3.  Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.

Authors:  Mitsuho Onimaru; Yoshikazu Yonemitsu; Mitsugu Tanii; Kazunori Nakagawa; Ichiro Masaki; Shinji Okano; Hiroaki Ishibashi; Kanemitsu Shirasuna; Mamoru Hasegawa; Katsuo Sueishi
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

4.  Fibroblast growth factor-hedgehog interdependence during retina regeneration.

Authors:  Jason R Spence; Juan-Carlos Aycinena; Katia Del Rio-Tsonis
Journal:  Dev Dyn       Date:  2007-05       Impact factor: 3.780

5.  Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.

Authors:  S Davis; T H Aldrich; P F Jones; A Acheson; D L Compton; V Jain; T E Ryan; J Bruno; C Radziejewski; P C Maisonpierre; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

6.  Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

Authors:  Ichiro Masaki; Yoshikazu Yonemitsu; Akihisa Yamashita; Shihoko Sata; Mitsugu Tanii; Kimihiro Komori; Kazunori Nakagawa; Xiaogang Hou; Yoshiyuki Nagai; Mamoru Hasegawa; Keizo Sugimachi; Katsuo Sueishi
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

7.  Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

Authors:  Richard P Visconti; Charlene D Richardson; Thomas N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

8.  Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia.

Authors:  Roberto Pola; Leona E Ling; Tamar R Aprahamian; Elena Barban; Marta Bosch-Marce; Cynthia Curry; Michael Corbley; Marianne Kearney; Jeffrey M Isner; Douglas W Losordo
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

9.  VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.

Authors:  Takaaki Fujii; Yoshikazu Yonemitsu; Mitsuho Onimaru; Makoto Inoue; Mamoru Hasegawa; Hiroyuki Kuwano; Katsuo Sueishi
Journal:  Atherosclerosis       Date:  2008-02-06       Impact factor: 5.162

10.  Inhibition of ocular neovascularization by hedgehog blockade.

Authors:  Enrico M Surace; Kamaljit S Balaggan; Alessandra Tessitore; Claudio Mussolino; Gabriella Cotugno; Ciro Bonetti; Aniello Vitale; Robin R Ali; Alberto Auricchio
Journal:  Mol Ther       Date:  2005-12-15       Impact factor: 11.454

View more
  15 in total

Review 1.  Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis.

Authors:  Christopher Lieu; John Heymach; Michael Overman; Hai Tran; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

Review 2.  FGF receptor inhibitors: role in cancer therapy.

Authors:  Gennaro Daniele; Jesus Corral; L Rhoda Molife; Johann S de Bono
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

3.  Delayed vasculogenesis and impaired angiogenesis due to altered Ang-2 and VE-cadherin levels in the chick embryo model following exposure to cadmium.

Authors:  A Gheorghescu; J Thompson
Journal:  Pediatr Surg Int       Date:  2015-12-01       Impact factor: 1.827

Review 4.  Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.

Authors:  Hyun-Jin Choi; Guillermo N Armaiz Pena; Sunila Pradeep; Min Soon Cho; Robert L Coleman; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

5.  Gli3 regulation of myogenesis is necessary for ischemia-induced angiogenesis.

Authors:  Marie-Ange Renault; Soizic Vandierdonck; Candice Chapouly; Yang Yu; Gangjian Qin; Alexandre Metras; Thierry Couffinhal; Douglas W Losordo; Qinyu Yao; Annabel Reynaud; Béatrice Jaspard-Vinassa; Isabelle Belloc; Claude Desgranges; Alain-Pierre Gadeau
Journal:  Circ Res       Date:  2013-09-17       Impact factor: 17.367

6.  Multivalent Conjugates of Sonic Hedgehog Accelerate Diabetic Wound Healing.

Authors:  Bruce W Han; Hans Layman; Nikhil A Rode; Anthony Conway; David V Schaffer; Nancy J Boudreau; Wesley M Jackson; Kevin E Healy
Journal:  Tissue Eng Part A       Date:  2015-09       Impact factor: 3.845

Review 7.  Tissue engineering strategies for promoting vascularized bone regeneration.

Authors:  Sarah Almubarak; Hubert Nethercott; Marie Freeberg; Caroline Beaudon; Amit Jha; Wesley Jackson; Ralph Marcucio; Theodore Miclau; Kevin Healy; Chelsea Bahney
Journal:  Bone       Date:  2015-11-19       Impact factor: 4.398

Review 8.  Bone Microvasculature: Stimulus for Tissue Function and Regeneration.

Authors:  Eun-Jin Lee; Mahim Jain; Stella Alimperti
Journal:  Tissue Eng Part B Rev       Date:  2020-10-22       Impact factor: 7.376

Review 9.  Angiogenesis and antiangiogenic agents in cervical cancer.

Authors:  Federica Tomao; Anselmo Papa; Luigi Rossi; Eleonora Zaccarelli; Davide Caruso; Federica Zoratto; Pierluigi Benedetti Panici; Silverio Tomao
Journal:  Onco Targets Ther       Date:  2014-12-03       Impact factor: 4.147

10.  Recombinant human sonic hedgehog protein regulates the expression of ZO-1 and occludin by activating angiopoietin-1 in stroke damage.

Authors:  Yuan-peng Xia; Quan-wei He; Ya-nan Li; Sheng-cai Chen; Ming Huang; Yong Wang; Yuan Gao; Yan Huang; Meng-die Wang; Ling Mao; Bo Hu
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.